Malta vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Malta
0
in 2018
United States of America
0.2907
in 2018
Malta rank
15th
United States of America rank
14th
Proportion of isolates with decreased susceptibility or resistance over time
- Malta
- United States of America
How they compare
United States of America currently reports 0.2907 against 0 in Malta, a difference of 0.2907.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was United States of America ahead.
Malta ranks 15th and United States of America ranks 14th of 27 countries.
Across the 2 decades both report, Malta averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Malta | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.7993 | 0.7993 | United States of America |
| 2010s | 0.8547 | 0.3382 | 0.5165 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Malta or United States of America?
- United States of America, at 0.2907 against 0 in Malta as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Malta and United States of America?
- 0.2907, with United States of America ahead.
- How many years of comparable data are there for Malta and United States of America?
- 10 years are reported by both, from 2009 to 2018.
- How do Malta and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Malta ranks 15th and United States of America ranks 14th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.